The largest database of trusted experimental protocols

10 protocols using her2 fc

1

Surface Plasmon Resonance Kinetics Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface plasmon resonance (SPR) experiments were performed using a Reichert SR7500C (Reichert Technologies, Depew, NY, USA) and a Biacore T200 instrument (GE Healthcare, Uppsala, Sweden). For HER2/FC (R&D Systems, Minneapolis, MN, USA), 1,100 relative unit proteins were captured on the protein-modified PEG sensor chip using an immobilization-capture wizard. We evaluated kinetics data using Scrubber2 (BioLogic Software Pty Ltd., Canberra, Australia) and Biacore T200 Control software version 2.0.1 and BIAevaluation software version 3.0 (GE Healthcare, Uppsala, Sweden).
+ Open protocol
+ Expand
2

Herceptin Binding Affinity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microtiter plates were coated with 4 μg/ml goat anti-rabbit Fc and incubated overnight. After one wash, 100 μl/well HER-2-ECD-rFc was added to each well and incubated overnight. HER-2-Fc and CD30-Fc chimeric proteins (R&D Systems, Minneapolis, MN) were serially diluted from a starting concentration of 10 ug/ml. Herceptin was added to a final concentration of 10 ng/ml in each of the serial chimeric protein dilutions. Plates were washed twice, and 50 μl/well of chimeric protein/Herceptin mixture was applied to the plate. Plates were then washed three times, and a 1:3000 dilution of HRP goat anti-human IgG was applied to each well, 50 μl/well. After four washes, 100 μl/well TMB substrate was added to each well. Development was stopped with 50 μl/well 2N H2SO4 after 5 minutes. Absorbance was measured at 450 nm with 690 nm absorbance subtracted.
+ Open protocol
+ Expand
3

Evaluating HER2-Specific CAR T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HER2-specific CAR T cells or UniCAR T cells (in the presence or absence of various concentrations of biotinylated trastuzumab) were plated onto 1 µg/ml HER2-Fc (R&D Systems, Minneapolis, MN, USA) pre-coated plates or cocultured with MDA-HER2 target cells (in the presence or absence of 10 µg/ml biotinylated trastuzumab) at a 1:1 effector to target ratio. Following 24 hours of culture, the supernatant was harvested and analyzed for the presence of interferon-gamma (IFNγ) by ELISA (R&D systems, Minneapolis, MN, USA) according to the manufacturer’s instruction using a Spark® multimode microplate reader (Tecan Group Ltd., Männedorf, Switzerland). The HER2- MDA-MB-468 cell line and NT T cells served as controls.
+ Open protocol
+ Expand
4

HER2-Specific CAR T Cell Expansion and Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
HER2.CD28.z and HER2.41BB.z CAR T cells were manufactured from OKT3-antiCD28/RPMI- and OKT3-RetroNectin/LymphoONE-stimulated PBMCs derived from four donors. Then, CAR T cell products were placed onto 1 µg/mL HER2-Fc (R&D Systems, Minneapolis, MN, USA) precoated plates. Every 3.5 days, effector cell number was determined by flow cytometry. At the same time, we calculated the proliferation rate by dividing the total effector cell number on the present day by the effector cells plated in the beginning of the last 3.5-day round. If the proliferation rate fell below 1, the available maximum amount of effector cells was placed onto fresh plates at the beginning of a new round. The experiment was concluded for a subset if the proliferation rate of the effector cells fell under 0.45.
At days 0, 3.5 and 10.5 of culturing, we analyzed the CD8/CD4 ratio and the memory phenotypes of the persisting CAR T cells by flow cytometry. Non-transduced (NT) T cells served as controls.
+ Open protocol
+ Expand
5

Cytokine and Receptor Protein Acquisition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human TNFα, IFNγ, TGFβ, IL-6 were purchased from Genentech Inc. (San Francisco, CA, USA). Human IL-1α was purchased from Sigma- Aldrich, (St. Louis, MO, USA). IL-7 and IL-15 were purchased from Peprotec (Rocky Hill, NJ). ALCAM-Fc, HER2-Fc were purchased from R&D Systems (Minneapolis, MN, USA).
+ Open protocol
+ Expand
6

HER2-specific CAR T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HER2-specific CAR T cells or UniCAR T cells (in the presence or absence of 10 µg/ml biotinylated trastuzumab; 2 × 105 cells/well) were placed onto flat-bottom plates pre-coated with 1 µg/ml HER2-Fc (R&D Systems, Minneapolis, MN, USA). Every 3.5 days, the effector cell number was determined by flow cytometry, and then the proliferation rate was calculated by dividing the total effector cell number on the present day by the number of effector cells plated at the beginning of the last 3.5-day round. A new round was initiated by re-plating 2 × 105 effector cells onto freshly coated plates. The effector cells did not receive interleukin supplements during the experiment. If the proliferation rate fell below 1, then the available maximum amount of effector cells was placed onto fresh plates at the beginning of a new round. The experiment was concluded for any subset when the proliferation rate of the effector cells fell under 0.45.
+ Open protocol
+ Expand
7

Enhancing NK Cell-Mediated HER2 Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 105 CD16.176 V.NK-92 cells (in the presence or absence of 10 µg/ml trastuzumab) were plated onto plates pre-coated with 1 µg/ml HER2-Fc (R&D Systems, Minneapolis, MN, USA) in complete NK cell medium supplemented with 0.01–30 µM Sunitinib. Following 24 h of culture, supernatant was harvested and analyzed for the presence of interferon-gamma (IFNγ) by ELISA (R&D systems, Minneapolis, MN, USA) according to the manufacturer's instruction using a Spark® Multimode Microplate Reader (Tecan, Switzerland).
+ Open protocol
+ Expand
8

Phage-ELISA and Indirect ELISA for HER2 Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For phage-ELISA, the wells of 96-well black plates (Thermo Fisher Scientific, Waltham, MA, USA) were coated with 1000 ng of HER2-Fc, streptavidin (Wako, Osaka, Japan), or IgG1-Fc (R&D systems) and blocked with 2% Perfect-Block (MoBiTec, Göttingen, Germany) in PBS for 1 h. Phages (1 × 1010 pfu) were added to each well and incubated for 1 h. After washing the plate, the bound phages were detected with the anti-T7 fiber tail antibody (Merck Millipore) as a primary antibody and the anti-mouse IgG HRP-linked antibody (Cell Signaling Technology, Danvers, MA, USA).
For indirect ELISA, the wells were first coated with 50 ng of HER2-Fc and then blocked with 2% Perfect-Block in PBS for 2 h. After incubation with sample proteins for 1 h, the HRP-conjugated anti-His-tag antibody (Abcam, Cambridge, MA, USA) was incubated for 1 h with the samples and then treated with the QuantaRed Enhanced Chemifluorescent HRP Substrate kit (Thermo Fisher Scientific). The resulting fluorescence was measured using an Infinite F500 (Tecan, Mannedorf, Switzerland) with specific filters (Ex/Em = 535 nm/590 nm).
For specificity evaluation, the wells were incubated overnight with HER2-Fc (50 ng/50 μL in PBS), EGFR-Fc (50 ng/50 μL in PBS; R&D systems), or 50 μL PBS, and applied to the indirect ELISA described above.
+ Open protocol
+ Expand
9

Screening Cyclic Peptide Libraries for HER2 Binders

Check if the same lab product or an alternative is used in the 5 most similar protocols
The T7 phage libraries displaying the random cyclic peptides X3CX8CX3 or X3CX9CX3, where X represents the randomized amino acids, were constructed using the T7 Select10-3b vector (Merck Millipore, Burlington, MA, USA), as described previously.19 (link) HER2-Fc (R&D systems, Minneapolis, MN, USA) was biotinylated using a labeling kit (Dojindo, Kumamoto, Japan) and immobilized on streptavidin-conjugated magnetic beads (Tamagawa Seiki, Nagano, Japan). The beads were blocked with 0.5% BSA in PBS, incubated with the phage libraries of X3CX8CX3 (1 × 1010 pfu) or X3CX9CX3 (1 × 1010 pfu) for 1 h, washed 30 times with PBS with 1% Tween 20 (1% PBST) and then added to 7 mL of E. coli BLT5403 cells (Merck Millipore) in log phase growth. After incubation at 37 °C and bacteriolysis, the phages were recovered from the culture supernatant by centrifugation (9100 g for 10 min at 4 °C) and used for the next round of biopanning. Amino acid sequences of displayed cyclic peptides on selected T7 phage clones were analyzed by DNA sequencing.
+ Open protocol
+ Expand
10

Cytokine and Receptor Protein Acquisition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human TNFα, IFNγ, TGFβ, IL-6 were purchased from Genentech Inc. (San Francisco, CA, USA). Human IL-1α was purchased from Sigma- Aldrich, (St. Louis, MO, USA). IL-7 and IL-15 were purchased from Peprotec (Rocky Hill, NJ). ALCAM-Fc, HER2-Fc were purchased from R&D Systems (Minneapolis, MN, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!